MS&AD Insurance Group (8725) Investor Day 2026 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2026 summary
26 May, 2026Vision and strategic direction
Aims to become a comprehensive global insurance provider, integrating non-life and life insurance for individuals and society worldwide, with a focus on international, domestic life, and domestic non-life businesses.
Raised FY2030 adjusted profit target from 700 billion yen to 800 billion yen, with an early-stage goal of 1 trillion yen and adjusted ROE at the 15% level.
Progressive dividend policy and continuous EPS growth targeted at 11% CAGR through FY2030.
Strategic equity holdings to be sold ahead of schedule, reallocating proceeds to growth investments and shareholder returns.
Financial targets and shareholder returns
FY2025 adjusted profit (IFRS) expected at 918.7 billion yen (525.5 billion yen excluding equity gains); FY2026 forecast at 800 billion yen (532 billion yen excluding equity gains).
Annual dividends projected at 160 yen for FY2025 and 170 yen for FY2026, with share buybacks totaling 270 billion yen in FY2026.
Shareholder return policy maintains a 50% payout of adjusted profit, with a shift from special to ordinary dividends as equity sales progress.
ESR (Economic Solvency Ratio) target set at over 180% to ensure financial soundness.
Growth strategies by business segment
International business targets 600 billion yen profit in the early 2030s, focusing on US expansion, group synergies, and a new management structure with multinational talent.
Domestic life insurance to expand asset-building products, leveraging MassMutual partnership and restructuring for optimal governance.
Domestic non-life insurance aims for 150 billion yen in cost reductions by FY2030, ongoing premium rate revisions, and enhanced collaboration in auto insurance.
Asset management strengthened by investment in Barings, expanding global investment capabilities and risk-taking.
Latest events from MS&AD Insurance Group
- Profit surged on strong non-life and international results; IFRS to impact future net income.8725
Q4 202620 May 2026 - Premiums, income, and solvency rose; major merger and strong non-life growth announced.8725
Q3 202613 Feb 2026 - Profit growth, Barings LLC investment, and higher capital returns marked the period.8725
Q2 202619 Nov 2025 - Net income rose 9.1% to 222.7 billion yen, led by strong non-life and overseas premium growth.8725
Q1 20268 Aug 2025 - Net income soared 424.5% on investment gains and lower losses, with forecasts and dividends raised.8725
Q2 202513 Jun 2025 - Net income and ordinary profit soared, led by overseas and investment gains.8725
Q1 202513 Jun 2025 - Record profit achieved, but next year's earnings are forecast to decline amid market risks.8725
Q4 20256 Jun 2025 - Net income more than doubled, driven by investment gains and strong overseas growth.8725
Q3 20256 Jun 2025